• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Chromocell Therapeutics Corp (NY: CHRO )

    1.255 +0.175 (+16.20%)
    Official Closing Price Updated: 4:10 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 170,652
    Open 1.140
    Bid (Size) 1.220 (3)
    Ask (Size) 1.290 (4)
    Prev. Close 1.080
    Today's Range 1.070 - 1.440
    52wk Range 1.060 - 6.000
    Shares Outstanding 23,083,169,588
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    CHRO Stock Earnings: Chromocell Therapeutics Reported Results for Q1 2024
    Chromocell Therapeutics just reported results for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -73.85%
    -73.85%
    1 Month
    -16.33%
    -16.33%
    3 Month
    -10.36%
    -10.36%
    6 Month
    -73.85%
    -73.85%
    1 Year
    -73.85%
    -73.85%

    More News

    Read More
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Ride-Hailing Startup Ryde Makes Public Debut
    Via Talk Markets
    Topics Initial Public Offering
    Exposures Securities Market
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.